Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Curebase Secures $40 Million in Series B Funding
Curebase, a company committed to democratizing access to clinical studies, has raised $40 million in […]
Immunicum AB: Immunicum Appoints Leopold Bertea as Chief Technology Officer
Immunicum AB (“Immunicum” publ; IMMU.ST), a biopharmaceutical company focused on therapies addressing tumor recurrence and hard-to-treat […]
Mologic and Alamar Biosciences Collaborate to Develop a next Generation COVID-19 Antigen Test
Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable […]
GSK Announces Dr Vishal Sikka to Join the Board as Non-executive Director
GlaxoSmithKline plc (LSE/NYSE: GSK) has today announced that Dr Vishal Sikka, founder and CEO of […]
Asceneuron Awarded Second Grant from The Michael J. Fox Foundation for Accelerated Research into Novel Parkinson's Disease Therapies
Asceneuron SA, a clinical stage company dedicated to targeting the root causes of neurodegenerative diseases, today […]
Overjet Partners with Dental Care Alliance, Providing AI to Improve Patient Outcomes
Overjet, a leader in dental artificial intelligence solutions for providers and payers, today announced a […]
AdBio Partners Welcomes Inserm Transfert As Investor in Second Fund – AFB Fund II
AdBio partners, an AMF-regulated (the French financial market authority) investment company dedicated to life sciences, […]
Gilead and Dragonfly Announce Strategic Research Collaboration to Develop Natural Killer Cell Engagers in Oncology and Inflammation
Gilead Sciences, Inc. (Nasdaq: GILD) and Dragonfly Therapeutics today announced a collaboration designed to advance […]
LifeOmic Deploys AI Solution With xCures to Improve Cancer Research and Treatment
LifeOmic, a software company that leverages the cloud, machine learning and mobile devices to power […]
HealthBeats Raises US$3m Seed Funding Led By Heritas Capital And SEEDS Capital To Expand Remote Vitals Monitoring In Australia And Singapore
HealthBeatsTM, a Singapore-based healthtech start-up with end-to-end remote vitals monitoring solution, today announced the close of […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more